Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Urol. doi: /nrurol

Published byCora Lawrence Modified over 6 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Urol. doi: /nrurol"— Presentation transcript:

1 Nat. Rev. Urol. doi:10.1038/nrurol.2018.9
Figure 3 Heterogeneous immunohistochemical expression of ERG and PTEN in prostate tumours Figure 3 | Heterogeneous immunohistochemical expression of ERG and PTEN in prostate tumours. a | Heterogeneous phosphatase and tensin homologue (PTEN) loss is observed in some tumour glands (N), with intact staining in other tumour glands (P), whereas the same areas are uniformly positive for ERG expression, indicating that clonal ERG genomic rearrangement is probably present with subsequent subclonal PTEN loss. b | Heterogeneous PTEN loss is seen in some tumour glands (N), with intact staining in other tumour glands (P), whereas the same areas are uniformly negative for ERG expression (ERG genomic rearrangement is absent). Jamaspishvili, T. et al. (2018) Clinical implications of PTEN loss in prostate cancer Nat. Rev. Urol. doi: /nrurol

Download ppt "Nat. Rev. Urol. doi: /nrurol"

Similar presentations

Tyrosine kinase signalling (review) TGF signalling Notch signalling.

Tyrosine kinase signalling (review) TGF signalling Notch signalling.
Figure 1 The heterogenous landscape of triple-negative breast cancer

Figure 1 The heterogenous landscape of triple-negative breast cancer
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 2 Recruitment of experts to the Delphi study

Figure 2 Recruitment of experts to the Delphi study
Figure 5 Mutational heterogeneity in oesophageal and gastric cancer

Figure 5 Mutational heterogeneity in oesophageal and gastric cancer
Figure 1 Concept of the therapeutic index

Figure 1 Concept of the therapeutic index
George J. Netto, Marie-Lisa Eich, Sooryanarayana Varambally 

George J. Netto, Marie-Lisa Eich, Sooryanarayana Varambally 
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology

Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology
Figure 5 Schematic illustration of different clinical trial designs

Figure 5 Schematic illustration of different clinical trial designs
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 3 Semantic model of the active surveillance (AS) timeline
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2

Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2
Figure 2 Copy-number variations in multiple myeloma

Figure 2 Copy-number variations in multiple myeloma
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Representative images from a right radical

Figure 2 Representative images from a right radical

Similar presentations

Ads by Google